Author:
Santos-Lazaro David,Gavilan Ronnie G.,Solari Lely,Vigo Aiko N.,Puyen Zully M.
Abstract
AbstractPeru has the highest burden of multidrug-resistant tuberculosis in the Americas region. Since 1999, the annual number of extensively drug-resistant tuberculosis (XDR-TB) Peruvian cases has been increasing, becoming a public health challenge. The objective of this study was to perform genomic characterization of Mycobacterium tuberculosis strains obtained from Peruvian patients with XDR-TB diagnosed from 2011 to 2015 in Peru. Whole genome sequencing (WGS) was performed on 68 XDR-TB strains from different regions of Peru. 58 (85.3%) strains came from the most populated districts of Lima and Callao. Concerning the lineages, 62 (91.2%) strains belonged to the Euro-American Lineage, while the remaining 6 (8.8%) strains belonged to the East-Asian Lineage. Most strains (90%) had high-confidence resistance mutations according to pre-established WHO-confident grading system. Discordant results between microbiological and molecular methodologies were caused by mutations outside the hotspot regions analysed by commercial molecular assays (rpoB I491F and inhA S94A). Cluster analysis using a cut-off ≤ 10 SNPs revealed that only 23 (34%) strains evidenced recent transmission links. This study highlights the relevance and utility of WGS as a high-resolution approach to predict drug resistance, analyse transmission of strains between groups, and determine evolutionary patterns of circulating XDR-TB strains in the country.
Funder
Programa Nacional de Innovación para la Competitividad y Productividad, Peru
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. World Health Organization. Global Tuberculosis Report 2020. (2020).
2. World Health Organization. Global Tuberculosis Report 2019. (2019).
3. Günther, G. et al. Multidrug-resistant tuberculosis in Europe, 2010–2011. Emerg. Infect. Dis. 21, 409–416 (2015).
4. Matteelli, A., Roggi, A. & Carvalho, A. C. Extensively drug-resistant tuberculosis: Epidemiology and management. Clin. Epidemiol. 6, 111–118 (2014).
5. Günther, G. et al. Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET survey. Eur. Respir. J. 45, 1081–1088 (2015).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献